Glenmark Pharmaceuticals NSE
597.75 00.00 (1.04%)
Glenmark Pharmaceuticals share price as of last closing was 597.75 on . As on date, the market capitalization of the company is Rs. 17,178.40 Crores and the book value of the same is Rs 633.57 Crores. As per NSE data, in last traded details the quantity of shares traded for Glenmark Pharmaceuticals were . For the last 1 year period, Glenmark Pharmaceuticals share price saw 1-year high of 629.85 and 1-year low of 348.50. If you would have invested in Glenmark Pharmaceuticals share,... based on its share price your 1-year return on same would be 56.67%, on a 3-year investment period the return would be 56.83% and on a 5 year investment period the return would be 12.90%. In the financial year 2021-22, Glenmark Pharmaceuticals registered a net income of 12482.71 Cr. The company’s EPS stood at 33.37 while P/E Ratio stood at 10.85. While, analysing Share Price of a company is crucial, it is equally important to look at the Stock Performance, Fundamental Analysis, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.
Markets Today
High | 612.60 |
Open at | 597.65 |
Volumes | 988742 |
Lower Circuit | 2100.00 |
Low | 596.00 |
Prev Close | 597.75 |
Avg Price | 2205.85 |
Upper Circuit | 2400.00 |
Last Traded Details
Quantity | 92,923 |
Time | 13:46:05 |
Historical Performance
1-Year High | 629.85 |
3-Year High | 690.95 |
5-Year High | 711.90 |
1-Year Low | 348.50 |
3-Year Low | 348.50 |
5-Year Low | 161.65 |
1-Year Performance Indicator
Company Valuation
Market Cap (₹ Cr.) | 17,178.40 |
Book Value (₹) | 633.57 |
Face Value (₹) | 1.00 |
P/E ratio | 10.85 |
Dividend Yield | 0.41 % |
Income Statements
Financial Year | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
All Expenditure (Cr) | 10,245.52 | 8,859.55 | 8,942.89 | 8,279.67 | 7,487.70 |
Operating Profit (Cr) | 20.26 | 19.91 | 17.77 | 18.18 | 18.75 |
EBIDTA (Cr) | 488.07 | 531.92 | 542.71 | 403.19 | 396.39 |
Profit Before Tax (Cr) | 1,441.25 | 1,382.48 | 1,096.08 | 1,300.63 | 1,119.33 |
Tax (Cr) | 447.60 | 412.39 | 320.11 | 375.63 | 315.46 |
Net Income (Cr) | 12,482.71 | 11,227.94 | 10,705.37 | 10,299.46 | 9,032.11 |
EPS (Cr) | 33.37 | 34.38 | 27.50 | 32.78 | 28.49 |
DPS (Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
In Short term
In Long term
1 Week | 3.08% |
1 Month | 12.08% |
3 Months | 45.47% |
6 Months | 40.15% |
9 Months | 64.91% |
1 Year | 56.67% |
2 Years | -0.85% |
3 Years | 56.83% |
4 Years | 11.58% |
5 Years | 12.90% |
Glenmark Pharmaceuticals share price as of today is Rs. . The company has a market capitalization of Rs. 17,178.40 with a P/E ratio of 10.85. Over the past 1 year, Glenmark Pharmaceuticals’s share price has moved by 56.67% while the 5-year performance of the stock stands at 12.90%. You’d also be interested to know that Glenmark Pharmaceuticals's share price has a 1-year low of ₹ 348.50 and a 1-year high of ₹ 629.85.
The Glenmark Pharmaceuticals share hit a 1-year low of Rs. 348.50 and a 1-year high of Rs. 629.85. The current market capitalization of Glenmark Pharmaceuticals is Rs. 17,178.40. While past performance does not guarantee future performance, the past 1-year return of Glenmark Pharmaceuticals share was 56.67% while the 5-year return was 12.90%.
Glenmark Pharmaceuticals share price has moved by 56.67% in the past 1 year. During the same time, the stock hit a 1-year high of Rs. 629.85 and a 1-year low of Rs. 348.50. As far as the long-term trend is concerned, the 5-year performance of Glenmark Pharmaceuticals share stands at 12.90%
Glenmark Pharmaceuticals has a market capitalization of Rs. 17,178.40 as of today, while the share price stands at . The market cap has moved by 56.67% in the past year and 12.90% in the past 5 years.
As a stock investor, you’d be interested in knowing that Glenmark Pharmaceuticals share price has a P/E ratio of 10.85 as of today. Along with the P/E ratio, the book value of Glenmark Pharmaceuticals’s stock is Rs. 633.57
Domestic Institutional Investors (DIIs) have a share in Glenmark Pharmaceuticals whereas Foreign Institutional Investors (FIIs) hold . The split between DIIs and FIIs is a crucial metric that stock investors track to gauge the market sentiment around the stock. The company’s promoters own of Glenmark Pharmaceuticals while non-promoters have a stake.
You can buy Glenmark Pharmaceuticals shares using the Dhan Trading App or Web Trading Platform. Follow these steps to get started:
If you have little money and want to buy Glenmark Pharmaceuticals stocks,Margin Trading Facility (MTF) is just the thing you need! MTF allows you to buy more with less. In fact, you can buy up to 4x more, which means you pay 25% and Dhan pays 75% for buying Glenmark Pharmaceuticals stocks.